Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,234.80
(
0.42%
)
Dow Jones
46,993.26
(
0.00%
)
Brent Oil
102.13
(
1.47%
)
Bitcoin
72,730.83
(
-1.64%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

go seek

Send PM Follow Ignore
Followers 23
Posts 5144
Boards Moderated 0
Alias Born 06/24/2006

go seek

Re: DewDiligence post# 34934

Friday, 10/06/2006 9:46:02 PM

Friday, October 06, 2006 9:46:02 PM

Post# of 257253
How do you see the HGSI / NVS collaboration (phase 3 start)
visa ve development of NM283?

Certainly NVS is doing more than spinning the wheel of fortune for potential drug winners in HCV treatment.

At the same time, how many potential $500M collaborations (given milestones) can NVS realistically afford to enter?

ie. does the fact NVS is dealing w/ HGSI diminish the shine on NM283?

Happy October to all!

The creation of a thousand forests is in one acorn.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now